Credit Suisse analyst Christoph Gretler lowered the firm’s price target on Fresenius Medical to EUR 32 from EUR 37 and keeps a Neutral rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FMS:
- Fresenius Medical price target lowered to EUR 27 from EUR 38 at UBS
- Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley
- Fresenius Medical price target lowered to EUR 34 from EUR 36 at Barclays
- Fresenius Medical price target lowered to EUR 17.10 from EUR 23 at JPMorgan
- Fresenius Medical price target lowered to EUR 36 from EUR 40 at Barclays
